Digitalis (fourth of four parts).
D000818:Animals; D000906:Antibodies; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002301:Cardiac Glycosides / Q000506:poisoning; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004070:Digitalis / Q000494:pharmacology / Q000506:poisoning*; D004071:Digitalis Glycosides / Q000378:metabolism / Q000506:poisoning* / Q000633:toxicity; D004285:Dogs; D004554:Electric Countershock; D006207:Half-Life; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007140:Immunoglobulin Fab Fragments; D008012:Lidocaine / Q000627:therapeutic use; D009461:Neurologic Manifestations; D010672:Phenytoin / Q000627:therapeutic use; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011188:Potassium / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use
D000906:Antibodies; D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D007140:Immunoglobulin Fab Fragments; D002792:Cholestyramine Resin; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D011188:Potassium